日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Management of vascular access inflow-outflow imbalance: A bimodal approach

血管通路入流-出流失衡的管理:双模式方法

Beathard, Gerald A; Jennings, William C; Malik, Jan; Wasse, Haimanot; Dolmatch, Bart L; Ross, John; Shenoy, Surendra; Pabir, Roy-Chaudhury; Sachdeva, Bharat; Rajan, Dheeraj; Niyyar, Vandana Dua; Nassar, George M; Peden, Eric; Lee, Timmy; McLennan, Gordon; Shahverdyan, Robert

Keep Seeking the Holy Grail: Predictive Modeling of Arteriovenous Fistula Maturation and Survival

继续探寻圣杯:动静脉瘘成熟和存活的预测模型

Wasse, Haimanot; Hentschel, Dirk M

Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling

SARS-CoV-2 急性期后遗症期间真菌移位标志物升高,并诱导 NF-κB 信号通路。

Giron, Leila B; Peluso, Michael J; Ding, Jianyi; Kenny, Grace; Zilberstein, Netanel F; Koshy, Jane; Hong, Kai Ying; Rasmussen, Heather; Miller, Gregory E; Bishehsari, Faraz; Balk, Robert A; Moy, James N; Hoh, Rebecca; Lu, Scott; Goldman, Aaron R; Tang, Hsin-Yao; Yee, Brandon C; Chenna, Ahmed; Winslow, John W; Petropoulos, Christos J; Kelly, J Daniel; Wasse, Haimanot; Martin, Jeffrey N; Liu, Qin; Keshavarzian, Ali; Landay, Alan; Deeks, Steven G; Henrich, Timothy J; Abdel-Mohsen, Mohamed

Vascular Suitability for an Endovascular Arteriovenous Fistula: Getting Beyond the Velvet Rope

血管适合进行血管内动静脉瘘手术:突破重重障碍

Wasse, Haimanot

Efficacy and safety associated with the use of the Surfacer(®) Inside-Out(®) Access Catheter System: Results from a prospective, multicenter Food and Drug Administration-approved Investigational Device Exemption study

Surfacer® Inside-Out® 导管系统的有效性和安全性:一项前瞻性、多中心、经美国食品药品监督管理局批准的研究性器械豁免研究的结果

Razavi, Mahmood K; Peden, Eric K; Sorial, Ehab; Ross, John R; Aruny, John E; Pflederer, Timothy A; Wasse, Haimanot; Haskal, Ziv J

Place of Percutaneous Fistula Devices in Contemporary Management of Vascular Access

经皮动静脉瘘装置在现代血管通路管理中的地位

Wasse, Haimanot

Association Between Type of Vascular Access Used in Hemodialysis Patients and Subsequent Kidney Transplant Outcomes

血液透析患者血管通路类型与后续肾移植结果之间的关联

Airy, Medha; Lenihan, Colin R; Ding, Victoria Y; Montez-Rath, Maria E; Cheng, Jizhong; Navaneethan, Sankar D; Wasse, Haimanot; Winkelmayer, Wolfgang C

Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access

动静脉透析通路介入研究的定义和终点

Beathard, Gerald A; Lok, Charmaine E; Glickman, Marc H; Al-Jaishi, Ahmed A; Bednarski, Donna; Cull, David L; Lawson, Jeffery H; Lee, Timmy C; Niyyar, Vandana D; Syracuse, Donna; Trerotola, Scott O; Roy-Chaudhury, Prabir; Shenoy, Surendra; Underwood, Margo; Wasse, Haimanot; Woo, Karen; Yuo, Theodore H; Huber, Thomas S

Recommended Clinical Trial End Points for Dialysis Catheters

透析导管临床试验推荐终点

Allon, Michael; Brouwer-Maier, Deborah J; Abreo, Kenneth; Baskin, Kevin M; Bregel, Kay; Chand, Deepa H; Easom, Andrea M; Mermel, Leonard; Mokrzycki, Michele H; Patel, Priti R; Roy-Chaudhury, Prabir; Shenoy, Surendra; Valentini, Rudolph P; Wasse, Haimanot

Clinical Trial End Points for Hemodialysis Vascular Access: Background, Rationale, and Definitions

血液透析血管通路临床试验终点:背景、原理和定义

Shenoy, Surendra; Allon, Michael; Beathard, Gerald; Brouwer-Maier, Deborah; Dember, Laura M; Glickman, Mark; Lee, Celeste; Litchfield, Terry; Lok, Charmaine; Huber, Thomas; Roy-Chaudhury, Prabir; Work, Jack; West, Melissa; Wasse, Haimanot